Swiss group Schweizerhall has continued its strategy of converting intoan industrial holding company by selling off its international activities in Pharma Distribution unit to Aceto Corp of the USA in return for a 10% stake in the latter.
Schweizerhall finance director Konrad Wirz said the sale had been forced by international pharmaceutical distribution market trends. He added that the company was not strong enough on its own to survive in this sector in the long term. Drug distribution in Switzerland, however, will remain unaffected by the sell-off and will be incorporated into the Chemie Schweiz division of the group. Sales of Pharma Distribution last year reached 160 million Swiss francs ($97.6 million).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze